{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:34:34Z","timestamp":1781206474795,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pediatric drug-induced hyperglycemia\/diabetes mellitus (DIH\/DIDM) is regarded as a preventable iatrogenic condition; nevertheless, its clinical under-recognition persists, and age-specific pharmacovigilance evidence remains critically deficient. This study conducted a retrospective pharmacovigilance investigation to identify risk signals associated with pediatric DIH\/DIDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>We extracted pediatric (age &amp;lt; 18 years) adverse-event reports from the FDA Adverse Event Reporting System (2004 Q1\u20132025 Q1) and retained those mapped to any of nine predefined MedDRA Preferred Terms (PTs) for hyperglycemia or diabetes mellitus. A disproportionality analysis was subsequently performed to estimate the reporting association between suspect drugs and the events of interest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We mined 504,458 pediatric adverse-event reports from the U.S. FDA Adverse Event Reporting System (2004Q1\u20132025Q1) and detected 195 positive drug\u2013adverse event signals. Among 2,436 pediatric DIH\/DIDM cases, 72% were adolescents aged 10\u201318 years; the overall median age was 13 years (IQR 9\u201316). Antineoplastic agents, glucocorticoids, immunosuppressants, psychotropic medications, and growth hormone constituted five cardinal risk clusters, and Off-label signals for drugs\u2014including minocycline and montelukast\u2014were captured for the first time. Underlying conditions were predominantly acute lymphoblastic leukemia, neuropsychiatric disorders, immunosuppression-related disorders, and growth hormone deficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study systematically delineated the risk signals implicated in pediatric DIH\/DIDM. Clinicians should heighten surveillance when prescribing potentially diabetogenic agents and pay particular attention to age-related windows of susceptibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1751155","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:22:51Z","timestamp":1769577771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A real-world investigation of drug-induced hyperglycemia and diabetes mellitus in pediatric populations using the FDA adverse event reporting system"],"prefix":"10.3389","volume":"13","author":[{"given":"Xue","family":"Zhao","sequence":"first","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiutian","family":"Sun","sequence":"additional","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ma","sequence":"additional","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Teng","sequence":"additional","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Qu","sequence":"additional","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S2213-8587(23)00025-6","article-title":"Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for diabetes in youth study.","volume":"11","author":"Wagenknecht","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-025-03890-w","article-title":"Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021.","volume":"23","author":"Chen","year":"2025","journal-title":"BMC Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study.","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012.","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5511049","DOI":"10.1155\/2023\/5511049","article-title":"Incidence trends of type 2 diabetes mellitus, medication-induced diabetes, and monogenic diabetes in Canadian children, then (2006-2008) and Now (2017-2019).","volume":"2023","author":"Patel","year":"2023","journal-title":"Pediatr Diabetes."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e000801","DOI":"10.1136\/bmjdrc-2019-000801","article-title":"Medication-induced hyperglycemia: pediatric perspective.","volume":"8","author":"Tosur","year":"2020","journal-title":"BMJ Open Diabetes Res Care."},{"key":"B7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.5114\/pedm.2022.118398","article-title":"Atypical diabetes mellitus in children - when to suspect drug-induced diabetes. A case-based review of the literature.","volume":"28","author":"Okruszko","year":"2022","journal-title":"Pediatr Endocrinol Diabetes Metab."},{"key":"B8","doi-asserted-by":"publisher","first-page":"865913","DOI":"10.3389\/fendo.2022.865913","article-title":"Case report: reversible hyperglycemia following rapamycin treatment for atypical choroid plexus papilloma in an infant.","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/dbi18-0002","article-title":"Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors.","volume":"67","author":"Stamatouli","year":"2018","journal-title":"Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/cpt.546","article-title":"Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus.","volume":"101","author":"Chakkera","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fnins.2017.00643","article-title":"Molecular mechanisms of antipsychotic drug-induced diabetes.","volume":"11","author":"Chen","year":"2017","journal-title":"Front Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1111\/bcp.14958","article-title":"Current knowledge, challenges and innovations in developmental pharmacology: a combined conect4children expert group and European society for developmental, perinatal and paediatric pharmacology white paper.","volume":"88","author":"Smits","year":"2022","journal-title":"Br J Clin Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s43441-023-00542-0","article-title":"Characterization of pediatric reports in the US food and drug administration adverse event reporting system from 2010-2020: a cross-sectional study.","volume":"57","author":"Phan","year":"2023","journal-title":"Ther Innov Regul Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapsychiatry.2015.2923","article-title":"Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis.","volume":"73","author":"Galling","year":"2016","journal-title":"JAMA Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/pedi.12562","article-title":"Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: who is worse off?","volume":"19","author":"Arslanian","year":"2018","journal-title":"Pediatr Diabetes."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e29505","DOI":"10.1002\/pbc.29505","article-title":"Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration.","volume":"69","author":"Pollock","year":"2022","journal-title":"Pediatr Blood Cancer."},{"key":"B17","unstructured":"\u201cCyclophosphamide Injection and Tablets: Prescribing Information.\n          \n          2013"},{"key":"B18","unstructured":"\u201cDepoCyt (Cytarabine Liposome Injection): Prescribing Information.\n          \n          2014"},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2165\/00002018-199615020-00005","article-title":"Drug-induced disorders of glucose metabolism. Mechanisms and management.","volume":"15","author":"Chan","year":"1996","journal-title":"Drug Saf."},{"key":"B20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/pbc.20320","article-title":"Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia.","volume":"45","author":"Baillargeon","year":"2005","journal-title":"Pediatr Blood Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1530\/EDM-18-0064","article-title":"Diabetic ketoacidosis following PEG-asparaginase therapy.","volume":"2018","author":"Ahmad","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/BLCTT.S245210","article-title":"Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: a Review.","volume":"11","author":"Bender","year":"2021","journal-title":"Blood Lymphat Cancer."},{"key":"B23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/aje\/kwaa197","article-title":"Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous thromboembolism in children.","volume":"190","author":"Horton","year":"2021","journal-title":"Am J Epidemiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","article-title":"Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review.","volume":"6","author":"Tamez-P\u00e9rez","year":"2015","journal-title":"World J Diabetes."},{"key":"B25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13300-023-01393-6","article-title":"Practical guide to glucocorticoid induced hyperglycaemia and diabetes.","volume":"14","author":"Barker","year":"2023","journal-title":"Diabetes Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biomedicines12030494","article-title":"The implications of cytochrome P450 2D6\/CYP2D6 polymorphism in the therapeutic response of atypical antipsychotics in adolescents with psychosis-a prospective study.","volume":"12","author":"Cojocaru","year":"2024","journal-title":"Biomedicines."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s13300-024-01628-0","article-title":"Medication-induced hyperglycemia and diabetes mellitus: a review of current literature and practical management strategies.","volume":"15","author":"Jain","year":"2024","journal-title":"Diabetes Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00467-022-05669-0","article-title":"Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study.","volume":"38","author":"Salah","year":"2023","journal-title":"Pediatr Nephrol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e002710","DOI":"10.1136\/bmjpo-2024-002710","article-title":"\u201cEffect of post-kidney transplant diabetes mellitus on long-term outcomes in a cohort of pediatric kidney transplant recipients from 2005 to 2022\u201d; survival analysis.","volume":"8","author":"Calvo-Herrera","year":"2024","journal-title":"BMJ Paediatr Open."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1080\/15548627.2022.2132686","article-title":"Impaired TFEB activation and mitophagy as a cause of PPP3\/calcineurin inhibitor-induced pancreatic \u03b2-cell dysfunction.","volume":"19","author":"Park","year":"2023","journal-title":"Autophagy."},{"key":"B31","doi-asserted-by":"publisher","first-page":"9131","DOI":"10.3390\/ijms23169131","article-title":"Fast tacrolimus metabolism does not promote post-transplant diabetes mellitus after kidney transplantation.","volume":"23","author":"Jehn","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/ajt.15665","article-title":"The tacrolimus-induced glucose homeostasis imbalance in terms of the liver: from bench to bedside.","volume":"20","author":"Ling","year":"2020","journal-title":"Am J Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jpeds.2013.04.045","article-title":"Metabolic safety of growth hormone in type 1 diabetes and idiopathic growth hormone deficiency.","volume":"163","author":"Bonfig","year":"2013","journal-title":"J Pediatr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(99)04055-6","article-title":"Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.","volume":"355","author":"Cutfield","year":"2000","journal-title":"Lancet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1297\/cpe.26.229","article-title":"Incidence of diabetes mellitus and neoplasia in Japanese short-statured children treated with growth hormone in the Genetics and neuroendocrinology of short stature international study (GeNeSIS).","volume":"26","author":"Yokoya","year":"2017","journal-title":"Clin Pediatr Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"811846","DOI":"10.3389\/fendo.2021.811846","article-title":"Safety of pediatric rhGH therapy: an overview and the need for long-term surveillance.","volume":"12","author":"Cianfarani","year":"2021","journal-title":"Front Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archdermatol.2008.521","article-title":"Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae.","volume":"145","author":"Brown","year":"2009","journal-title":"Arch Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1751155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:22:52Z","timestamp":1769577772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1751155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1751155"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1751155","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"article-number":"1751155"}}